Study of blood tests and scans in relapsing-remitting MS
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study follows adults with relapsing-remitting multiple sclerosis using MRI scans and blood tests. It aims to understand how the disease behaves and what markers in blood and imaging may relate to changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 59 (inclusive)
- Have relapsing-remitting multiple sclerosis and no relapse for at least 6 months
- Have an EDSS score under 6 (a measure of disability; lower usually means you can move independently)
- Not have primary progressive or secondary progressive MS at the start
- Be able to have MRI safely and follow scheduled follow-ups (including being able to give consent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced MRI scans to see how they can help doctors better understand multiple sclerosis (MS). It compares images from people with MS to those without MS to find differences that may improve diagnosis and treatment.
This study looks at whether people with relapsing-remitting MS can experience symptom flare-ups (relapses) that don't show up on MRI scans. Researchers want to understand if this happens and what it means for your care.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
This trial uses MRI scans to monitor spinal cord changes in people newly diagnosed with relapsing-remitting MS who have not yet started treatment. It aims to better understand how the disease progresses and could help guide early treatment decisions.
This is a long-term hospital study that follows people diagnosed with MS (and a few related conditions) to understand how disease changes over time. You may be asked to have regular check-ups, brain scans, and provide blood samples so researchers can track disease and treatment effects.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.